Federal Register #FDA-2025-N-4731

FDA Public Meeting on Increasing Access to Nonprescription Drugs

This notice announces a public meeting hosted by the Food and Drug Administration (FDA) to discuss increasing access to nonprescription drugs. - Government Buyer: - Department of Health and Human Services (HHS) - Food and Drug Administration (FDA) - Purpose: - Public meeting titled "Increasing Access to Nonprescription Drugs" - Soliciting perspectives and comments from stakeholders and the public - Participation Details: - Meeting held both virtually and in person - Registration required for attendance - Comments accepted electronically via regulations.gov or in writing to the FDA Dockets Management Staff - Procurement Details: - No products or services are being procured - No OEMs or vendors are mentioned - No unique procurement requirements - Locations: - In-person meeting at the National Press Club, Washington, DC - Written comments submitted to FDA Dockets Management Staff, Rockville, MD

Description

The Food and Drug Administration (FDA) is announcing a public meeting titled "Increasing Access to Nonprescription Drugs" to discuss perspectives from interested parties on increasing access to nonprescription drugs. The meeting will be held virtually and in person on April 23, 2026, from 12:30 p.m. to 5 p.m. Eastern Time. The FDA is also requesting comments on this topic, with submissions due by May 8, 2026. Registration is required for attendance, and comments can be submitted electronically or in writing.

View original listing